The Rising Cost of Prescription Drugs: Causes and.
Historic increases in prescription drug prices and spending are contributing to unsustainable health care costs in the United States. While rising prescription drug utilization is clearly a product of population growth, an aging population, and greater use of drugs in health care among all age groups, about one-third of the rise in prescription spending from 2010 to 2014 was a result of either.
Rising drug prices indicate that current policies need to be revisited. Conflict of interest The authors of the research paper (1) declared that there was no conflict of interest. Related articles Generics prices increase when competition decreases. Policies to address price rises in old generics. Reference 1. Conti RM, Nguyen KH, Rosenthal MB.
These results may follow from the typical design of prescription drug coverage, which reduces the purchase price of high-cost drugs by more than that of low-cost drugs. In any event, the differential impact on high- and low-cost drugs supports the argument that the observed insurance effect is due to the drug coverage itself rather than an improvement in medical coverage.
HEALTHCARE RESEARCH PAPER 2 Research Paper: Rising Costs of Prescription Drugs Introduction The hole in everyday Americans pockets just keeps getting bigger. With low wages and a higher cost of living, it’s getting harder to pay for the things you can’t live without. Nearly 60 percent of all Americans are taking some sort of prescription drug, at costs that are going through the roof (2015).
The first is the rising cost in prescription drugs. The second area of rising cost is the increased technologies when it comes to the medical industry. The third problem is the aging population.. By 1970 the rising cost of health care coverage as a percentage of the Gross Domestic Product of the United States caught political attention.
Prices for drugs are rising faster than inflation year after year, and these escalating prices have nothing to do with value or recoupment of long-ago research-and-development costs.
Prescription drug prices projected to rise 4.5% in 2020 -- health care expert available to comment on controlling rising costs Marianne G. Morgan, CEO of Easy Drug Card, available to comment on.